Key result
Five single nucleotide polymorphisms within GATA2 were significantly associated with early-onset coronary artery disease, with two validated in an independent case-control sample set.
Why the study?
Are GATA2 gene polymorphisms associated with early-onset coronary artery disease?
Case-Control
Are GATA2 gene polymorphisms associated with early-onset coronary artery disease?
GATA2 is identified as a novel susceptibility gene for early-onset coronary artery disease.
GATA2 variants may contribute to early-onset CAD susceptibility; hypothesis-generating and requires prospective validation before any clinical application.
The transcription factor GATA2 plays an essential role in the establishment and maintenance of adult hematopoiesis.It is expressed in hematopoietic stem cells, as well as the cells that make up the aortic vasculature, namely aortic endothelial cells and smooth muscle cells.We have shown that GATA2 expression is predictive of location within the thoracic aorta; location is suggested to be a surrogate for disease susceptibility.The GATA2 gene maps beneath the Chromosome 3q linkage peak from our family-based sample set (GENECARD) study of early-onset coronary artery disease.Given these observations, we investigated the relationship of several known and novel polymorphisms within GATA2 to coronary artery disease.We identified five single nucleotide polymorphisms that were significantly associated with early-onset coronary artery disease in GENECARD.These results were validated by identifying significant association of two of these single nucleotide polymorphisms in an independent case-control sample set that was phenotypically similar to the GENECARD families.These observations identify GATA2 as a novel susceptibility gene for coronary artery disease and suggest that the study of this transcription factor and its downstream targets may uncover a regulatory network important for coronary artery disease inheritance.
No takes yet. Share an insight, caveat, or question.
Connelly et al. (2005) conducted a case-control in early-onset coronary artery disease. GATA2 polymorphisms was evaluated on early-onset coronary artery disease. Five single nucleotide polymorphisms within GATA2 were significantly associated with early-onset coronary artery disease, with two validated in an independent case-control sample set.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: